A second-line antitubercular agent that inhibits mycolic acid synthesis. It also may be used for treatment of leprosy. (From Smith and Reynard, Textbook of Pharmacology, 1992, p868)
For use in the treatment of pulmonary and extrapulmonary tuberculosis when other antitubercular drugs have failed.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.